|
|
Please log in to edit this profile
|
| Elevator Pitch |
Nanopharmaceuticals are a revolutionary new approach to designing drugs within ultra-small particles and enhancing their properties with the goal of creating improved therapies for fighting disease. |
| Industry Focus |
BioPharma |
| Category |
Companies - Early Stage |
| Location |
161 First Street |
|
Cambridge, Massachusetts
02142
|
|
United States |
| |
| Phone |
617-551-9600 |
| Fax |
617-494-1544 |
| Email |
Please log in |
| Web |
http://www.ceruleanrx.com |
|
|
|
Amount: $500,000
Closed: July 28, 2009
|
|
|
|
|
|
|
Round: Series B
Amount: Unspecified
Closed: July, 2009
|
|
|
|
|
|
|
Round: Series B
Amount: Unspecified
Closed: July, 2009
|
|
|
|
|
|
|
Round: Series B
Amount: Unspecified
Closed: July, 2009
|
|
|
|
|
|
|
Round: Series B
Amount: Unspecified
Closed: July, 2009
|
|
|
|
| Be the first to recommend Cerulean Pharma!
Log in |
Public information, member edits, and the DealHorizon.com team.
|
Office Location
Statistics
Search Site
Edit/Update
Followers
Please log in
Note: Once associated with a listing, Executives are automatically included as followers of that listing. Listing
creators are also automatically added as followers.
|
